XML 38 R27.htm IDEA: XBRL DOCUMENT v3.6.0.2
Marketable Securities (Summary Of Cash Equivalents And Marketable Securities) (Details) - USD ($)
$ in Thousands
Jan. 01, 2017
Jul. 03, 2016
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost $ 1,451,905 $ 1,343,717
Unrealized Gain 352 1,939
Unrealized (Loss) [1] (650) (25)
Fair Value 1,451,607 1,345,631
Cash equivalents [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 171,789 161,028
Unrealized Gain 6 10
Unrealized (Loss) [1] (7)  
Fair Value 171,788 161,038
Marketable securities [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 1,280,116 1,182,689
Unrealized Gain 346 1,929
Unrealized (Loss) [1] (643) (25)
Fair Value 1,279,819 1,184,593
U.S. Treasury securities [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 475,678 441,925
Unrealized Gain 113 783
Unrealized (Loss) [1] (82) (5)
Fair Value 475,709 442,703
Obligations of U.S. government-sponsored enterprises [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 353,967 316,368
Unrealized Gain 175 855
Unrealized (Loss) [1] (261)  
Fair Value 353,881 317,223
Municipal bonds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 136,711 119,680
Unrealized Gain   158
Unrealized (Loss) [1] (256) (10)
Fair Value 136,455 119,828
Corporate debt securities and other [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 421,493 395,254
Unrealized Gain 64 143
Unrealized (Loss) [1] (51) (10)
Fair Value 421,506 395,387
Money market funds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 64,056 70,490
Fair Value $ 64,056 $ 70,490
[1] The Company evaluated the nature of the investments with a loss position at January 1, 2017 and July 3, 2016, which are primarily obligations of the U.S. government and its sponsored enterprises, municipal bonds and U.S. corporate notes. In evaluating the investments, the Company considered the duration of the impairments, and the amount of the impairments relative to the underlying portfolio and concluded that such amounts were not other-than-temporary. The Company principally holds securities until maturity, however, they may be sold under certain circumstances. Unrealized losses on the investments greater than twelve months old were not significant as of January 1, 2017 and July 3, 2016.